
Approximately 2,500 patients are expected to be eligible to receive the one-time therapy

If approved, the treatment would be the first gene therapy in the US for this indication

Approximately 20,000 adults are affected by haemophilia A across more than 70 countries in Europe, the Middle East and Africa

The decision follows data suggesting BioMarin’s experimental gene therapies may have the potential to progress cancers

The study for BMN 307 in genetic disease phenylketonuria will be paused while malignancies in mice are explored

Strong growth in women’s health and biosimilars is driving the new company, which expects 2021 growth in the “low to mid-single digit range”

Sales grew by 19% in the second quarter as key products begin to recover from the impact of the pandemic

GSK's vaccine business was up by 39% to £1.6bn thanks to the strong growth (46%) of its meningitis vaccine

Total revenue was up by 31% to $8.2bn and also increased by 24% to $15.2bn for the half year

COVID-19 vaccine generated $7.8bn in the second quarter of 2021 alone

Swiss pharma company also provided key updates on a number of drug candidates in its pipeline

Sales of immunotherapy Opdivo decreased due to COVID-19 impact